Cargando…
Editing and Chemical Modifications on Non-Coding RNAs in Cancer: A New Tale with Clinical Significance
Currently, for seemingly every type of cancer, dysregulated levels of non-coding RNAs (ncRNAs) are reported and non-coding transcripts are expected to be the next class of diagnostic and therapeutic tools in oncology. Recently, alterations to the ncRNAs transcriptome have emerged as a novel hallmark...
Autores principales: | Torsin, Ligia I., Petrescu, George E. D., Sabo, Alexandru A., Chen, Baoqing, Brehar, Felix M., Dragomir, Mihnea P., Calin, George A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827606/ https://www.ncbi.nlm.nih.gov/pubmed/33430133 http://dx.doi.org/10.3390/ijms22020581 |
Ejemplares similares
-
MicroRNA based theranostics for brain cancer: basic principles
por: Petrescu, George E. D., et al.
Publicado: (2019) -
Targeting non-coding RNAs to overcome cancer therapy resistance
por: Chen, BaoQing, et al.
Publicado: (2022) -
Fighting Cancer Stem Cell Fate by Targeting LIS1 a WD40 Repeat Protein
por: Brehar, Felix M., et al.
Publicado: (2019) -
Key questions about the checkpoint blockade-are microRNAs an answer?
por: Dragomir, Mihnea, et al.
Publicado: (2018) -
Circular RNAs in Cancer – Lessons Learned From microRNAs
por: Dragomir, Mihnea, et al.
Publicado: (2018)